Pain and Suction Curettage

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

111 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of the study was to investigate the analgesic efficacy of preoperative oral dexketoprofen trometamol, intravenous paracetamol, lidocaine spray and paracervical block with ultracaine on curettage procedure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Preemptive Analgesic Effects of Dexketoprofen Versus Dexmedetomidine on Abdominal Hysterectomy Patients

NCT02092012

Pain

UNKNOWN PHASE4

Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases

NCT05644873

Abdominal Hysterectomy General Anesthesia Magnesium Sulfate

COMPLETED NA

Efficacy of Intravenous Paracetamol and Ibuprofen on Postoperative Pain and Morphine Consumption in Hysterectomy

NCT04691856

Postoperative Pain Management

COMPLETED NA

Comparison of Perioperative Analgesia Between Intravenous Paracetamol and Fentanyl for Rigid Hysteroscopy

NCT04762147

Analgesia Effect of Drug

COMPLETED PHASE3

Postoperative Analgesic Effect Of Dexmedetomidine Administration in Wound Infiltration for Total Abdominal Hysterectomy

NCT01929252

Pain

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Curettage Analgesia Paracervical Block Paracetamol

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

paracetamol

Duration

Group Type ACTIVE_COMPARATOR

paracetamol

Intervention Type DRUG

without drug

Control group

Group Type ACTIVE_COMPARATOR

without drug

Intervention Type OTHER

dexketoprofen trometamol

Study group

Group Type ACTIVE_COMPARATOR

dexketoprofen trometamol

Intervention Type DRUG

two puff xylocain administration on cervical surface

Study group

Group Type ACTIVE_COMPARATOR

suction curettage

Intervention Type DRUG

paracervical block with ultracaine

study group

Group Type ACTIVE_COMPARATOR

suction curettage

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

paracetamol

Intervention Type DRUG

dexketoprofen trometamol

Intervention Type DRUG

suction curettage

Intervention Type DRUG

suction curettage

Intervention Type DRUG

without drug

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

two puff xylocain administration paracervical block with ultracaine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant participants between 35-48 days of gestation (5 to 7 weeks of gestation) pregnant participants with a single viable intrauterine pregnancy requesting termination of pregnancy.

Exclusion Criteria

incomplete abortions, diabetes mellitus, tendency to bleed such as thrombocytopenia, factor deficiency and functional disorders of platelets… etc, pelvic infection, known cervical stenosis, significantly impaired respiratory or cardiac conduction functions, active liver disease, renal disease, previous adverse reaction to any of the drugs used in the study, and patients who are unable to understand how to score a 10-cm visual analog scale (VAS) pain score. Moreover, patients who described chronic pelvic pain prior to the study or patients who rated their pain level on a continuous 100-mm VAS different from 0 (no pain) just before the study were not included into study.

Minimum Eligible Age

16 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes